Clinical Correlations of Biomarkers in Chronic Heart Failure Developed on the Background of Rheumatic Heart Disease
Keywords:
CHF, cystatin C, ischemic heart diseaseAbstract
With the increase in life expectancy worldwide, the prevalence and incidence of chronic heart failure (CHF) and cardiovascular diseases (CVD) are also rising. It is well known that CHF and renal dysfunction frequently coexist as comorbid conditions, contributing to the development of adverse outcomes in the cardiovascular continuum and increasing mortality [202, 61, 36, 1]. CHF has a pronounced negative impact on renal and glomerular hemodynamics. In recent years, many literature reviews have emphasized the interrelationship between the heart and kidneys, described by the term "cardiorenal syndrome," which encompasses complex mechanisms of pathophysiological changes.
References
1. Andrew A. House, Christoph Wanner, Mark J. Sarnak, Ileana L. Pina, Christopher W. McIntyre, Paul Komenda, Bertram L. Kasiske, Anita Deswal, Christopher R. deFilippi, John G.F. Cleland, Stefan D. Anker, Charles A. Herzog, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayerand Peter A. McCullough; for Conference Participants. KDIGO execut i v e conclusions - Kidney International (2019) 95, 1304–1317
2. Bock JS, Gottlieb SS. Cardiorenal syndrome. Circulation. 2010;121:2592–2600
3. Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R. Tubular damage and worsening renal function in chronic heart failure. JACC Heart Fail 2013;1:417–424. 5.
4. Driver TH, Katz R, Ix JH, Magnani JW, Peralta CA, Parikh CR, Fried L, Newman AB, Kritchevsky SB, Sarnak MJ, Shlipak MG, Health ABC Study. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis 2014;64:49–56. 6.
5. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, Bonventre JV, Voors AA, Hillege HL. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010;96:1297–1302
6. Di Lullo L, House A, Gorini A, et al. Chronic kidney disease and cardiovascular complications. Heart Fail Rev. 2015;20:259–272
7. Ebner N., Jankowska E.A., Ponikowski P., Lainscak M., Elsner S., Sliziuk V. et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities aggravating heart failure. Int. J. Cardiol. 2016; 6–12. DOI: 10.1016/j.ijcard.2015.11.178;
8. Femke Waanders M.D. et al. Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial // Am. J. Kidney Dis. — 2009. — Vol. 53,№ 1. — Р. 16-25.
9. Geng, J.; Qiu, Y.; Qin, Z.; Su, B. The Value of Kidney Injury Molecule 1 in Predicting Acute Kidney Injury in Adult Patients: A Systematic Review and Bayesian Meta-Analysis. J. Transl. Med. 2021, 19
10. Go A.S., Mozaffarian D., Roger V.L. et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association // Circulation. - 2014. - Vol. 129. №3. - P.28-292
11. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73:863–869
12. Ichimura et al. Kidney injury molecule-1 (KIM-1), a putativeepithelial cell adhesion molecule containing a novel immunoglobylindomain, is up-regulated in renal cells after injury //J. Biol. Chem. — 1998. — Vol. 273, № 7. — P. 4135-4142
13. Jungbauer C.G., Birner C., Jung B., Buchner S., Lubnow M., von Bary C., Endemann D., Banas B., Mack M., Böger C.A., Riegger G., Luchner A. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome // Eur. J. Heart Fail. — 2011. — Vol. 13, № 10. — Р. 1104-1110
14. Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, Achenbach S, Schmieder RE. Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction. ESC Heart Fail. 2021 Apr;8(2):1562-1570. doi: 10.1002/ehf2.13257. Epub 2021 Feb 9. PMID: 33559346; PMCID: PMC8006684
15. K. Damman, S. Masson, H. L. Hillege et al., “Clinical outcome of renal tubular damage in chronic heart failure,” European Heart Journal, vol. 32, no. 21, pp. 2705–2712, 2011
16. Michael H, Prasad D, Anja H-F, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury. J Am Coll Cardiol. 2011;57:1752–1761
17. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534–2543
18. McMurray J., McDonagh T., Morrison C.E., et al. Trends in hospitalization for the heart failure in Scotland. 1980-1990/ Eur. Heart J.-1993.-Vol14, №9.- P1158-1162.,
19. McNamara D.M. Pharmocogenetics in Heart Failure: Genomic markers of endothelial and neurohumoral function // Congestive Heart Failure. - 2004. - 10. - P. 302—308
20. Mozaffarian D., Benjamin E.J., Go A.S. et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics - 2016 Update: a report from the American Heart Association // Circulation. - 2016. – Vol. 135 . – P. 348 – 360
21. Pang, H.M.; Qin, X.L.; Liu, T.T.; Wei, W.X.; Cheng, D.H.; Lu, H.; Guo, Q.; Jing, L. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: A prospectivestudy. Eur Rev Med Pharmacol Sci. 2017, 21, 4203–4213. [PubMed],
22. R. Ghatanatti, A. Teli, S. S. Tirkey, S. Bhattacharya, G. Sengupta, and A. Mondal, “Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery,” Asian Cardiovascular and Thoracic Annals, vol. 22, no. 2, pp. 234–241, 2014.,
23. The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A Historical Perspective, Lancet. 2014 March 15; 383(9921): 999–1008. doi:10.1016/S0140-6736(13)61752-3
24. Vaidya V.S., Bobadila N.A., Bonventre J.V. Urinary kidney injury molecule — 1: a sensitive quantitative biomarker for early detection of kidney tubular injury // Am. J. Physiol. Renal. Physiol. — 2006. —Vol. 290, № 2. — P. 517-529.,
25. Vaidya V.S., Ford G.M., Waikar S.S. et al. A rapid urine test for early detection of kidney injury // Kidney Int. — 2009. — Vol. 76,№ 1. — P. 108-114
26. Агеев Ф. Т., Арутюнов Г. П., Беленков Ю. Н. и др. Хроническая сердечная недостаточность. – М., «ГЭОТАР-Медиа», 2010. – 336 с.
27. Калягин А.Н. Особенности курации больных с хронической ревматической болезнью сердца в современных условиях. // Труды 2-го Международонго форума «Актуальные проблемы современной науки» 20-23 ноября 2006г. Естественные науки. –Ч 27. Медицинские науки-Самара, 2006.- С30-33.
28. Калягин А.Н. Хроническая сердечная недостаточность:современное понимание проблемы. Особенности ведения больных с клапанными пороками сердца. Сибирский медицинский журнал., 2008, №4 ст 100-105
29. Калягин А.Н. Экологогигиенические факторы риска развития и прогрессирования хронической сердечной недостаточности при ревматических пороках сердца: Дисс. … канд. мед. наук. – Иркутск, 2004. – 152 с., .
30. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр) // Журнал Сердечная недостаточность. - 2013. - Tом. 14. № 7. - С. 379-472
31. Соболева М.К., Воропай Л.А., Курыгина С.В. Причины приобретенных пороков сердца // Тезисы III Съезда ревматологов. // Научнопрактическая ревматология. – 2001. – № 3. – С.108.,
32. Старжевская Л.Е., Морова Н.А., Цеханович В.Н. Мно2 гофакторная оценка степени хирургического риска у больных митральными пороками сердца // Актуальные проблемы кардиологии. Сборник тезисов 10 конференции с международным участием. – Тюмень, 2003. –С.108
33. Ткaчeнкo E.И., Бoрoвкoвa Н.Ю.,. Буянoвa М.В. Aнeмия при хрoничeскoй сeрдeчнoй нeдoстaтoчнoсти: взгляд нa пaтoгeнeз и пути кoррeкции. // Кaрдиoлoгия Тeрaпия № 2 (157), 2019. DOI: 10.31550/1727-2378-2019-157-2-31-36.
